Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
<p>Abstract</p> <p>Background</p> <p>Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.</p> <p>...
Main Authors: | Tan Boon, Ho Hanley J, Gao Qiuhan, Barr Ian, Yap Jonathan, Tay Joshua K, Lee Vernon J, Kelly Paul M, Tambyah Paul A, Kelso Anne, Chen Mark I |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/164 |
Similar Items
-
Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
by: Mithilesh Dronavalli, et al.
Published: (2020-04-01) -
Oseltamivir utilization during the 2009 H1N1 influenza pandemic, Taiwan
by: Chia-Ping Su, et al.
Published: (2011) -
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
by: Miller Joel C, et al.
Published: (2010-07-01) -
Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009
by: Wei-Yen Lim, et al.
Published: (2011-08-01) -
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
by: Maki Kiso, et al.
Published: (2010-08-01)